High IF1 levels are associated to a worse patient prognosis in bladder carcinomas (Wei et al., 2015), gliomas (Wu et al., 2015) and non-small-cell lung cancer (Gao et al., 2016). The gene discussed is ATP5IF1; the disease is non-small cell lung carcinoma.